Qu Biologics
CompanyCanada
Qu Biologics develops 4 assets, the furthest in phase 2 (QBECO SSI in colon cancer). Mostly other; based in Canada.
- 4
- Assets
- Furthest stage
- Phase 2
- Raised
- US$48.8k
- 0
- Trials
- 0
- Signals
Pipeline
4Inactivated E. coli components restore innate immune homeostasis in the gastrointestinal tract and related organs.
Phase 2, Other, colon cancer, Crohn's disease
Inactivated K. pneumoniae components restore innate immune homeostasis in the lungs and respiratory tract.
Phase 2, Other, decline in innate immune function in the elderly, recurrent lung cancer
Inactivated S. aureus components restore innate immune homeostasis in skin, soft tissue, and bone.
Stage not known, Other
1 more asset
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Funding rounds and grants1
- People9
- Similar companies6